Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles

References

• ZucoVSupinoRRighettiSCSelective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cellsCancer Lett20021751172511734332
   PubMed Web of Science ®Google Scholar
• BrajtburgJPowderlyWGKobayashiGSMedoffGAmphotericin B: delivery systemsAntimicrob Agents Chemother19903433813842185689
   PubMed Web of Science ®Google Scholar
• LemkeAKiderlenAFKayserOAmphotericin BAppl Microbiol Biotechnol200568215116215821914
   PubMed Web of Science ®Google Scholar
• CharbonneauCFournierIDufresneSBarwiczJTancrèdePThe interactions of amphotericin B with various sterols in relation to its possible use in anticancer therapyBiophys Chem200191212513311429202
   PubMed Web of Science ®Google Scholar
• ChenLYSheuMTLiuDZPretreatment with an ethanolic extract of Taiwanofungua camphoratus (Antrodia camphorata) enhances the cytotoxic effects of amphotericin BJ Agric Food Chem20115920112551126321899275
   PubMedGoogle Scholar
• GiroisSBChapuisFDecullierERevolBGPErratum: Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysisEur J Clin Microbiol Infect Dis200625213814916622909
   PubMedGoogle Scholar
• GallisHADrewRHPickardWWAmphotericin B: 30 years of clinical experienceRev Infect Dis19901223083292184499
   PubMedGoogle Scholar
• VandermeulenGRouxhetLArienABrewsterMEPreatVEncapsulation of amphotericin B in poly(ethylene glycol)-block-poly (epsilon-caprolactone-co-trimethylenecarbonate) polymeric micellesInt J Pharm20063091–223424016406402
   PubMedGoogle Scholar
• BarwiczJChristianSGrudaIEffects of the aggregation state of amphotericin B on its toxicity to miceAntimicrob Agents Chemother19923610231023151444311
   PubMedGoogle Scholar
• LegrandPRomeroEACohenBEBolardJEffects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytesAntimicrob Agents Chemother19923611251825221489196
   PubMed Web of Science ®Google Scholar
• HiemenzJWWalshTJLipid formulations of amphotericin B: recent progress and future directionsClin Infect Dis199622Suppl 2S133S1448722841
   PubMed Web of Science ®Google Scholar
• Wong-BeringerAJacobsRAGuglielmoBJLipid formulations of amphotericin B: clinical efficacy and toxicitiesClin Infect Dis19982736036189770163
   PubMed Web of Science ®Google Scholar
• GaucherGDufresneMHSantVPKangNMaysingerDLerouxJCBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Control Release20051091–316918816289422
   PubMed Web of Science ®Google Scholar
• TorchilinVPStructure and design of polymeric surfactant-based drug delivery systemsJ Control Release2001732–313717211516494
   PubMed Web of Science ®Google Scholar
• GongJChenMZhengYWangSWangYPolymeric micelles drug delivery system in oncologyJ Control Release2012159331232322285551
   PubMed Web of Science ®Google Scholar
• LuYParkKPolymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugsInt J Pharm2013453119821422944304
   PubMed Web of Science ®Google Scholar
• JonesMLerouxJPolymeric micelles – a new generation of colloidal drug carriersEur J Pharm Biopharm199948210111110469928
   PubMed Web of Science ®Google Scholar
• YokoyamaMPolymeric micelles as a new drug carrier system and their required considerations for clinical trialsExpert Opin Drug Deliv20107214515820095939
   PubMed Web of Science ®Google Scholar
• KrishnadasARubinsteinIOnyukselHSterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugsPharm Res200320229730212636171
   PubMed Web of Science ®Google Scholar
• JinXZhangZ-hSunEPreparation of icariside II-phospholipid complex and its absorption across Caco-2 cell monolayersPharmazie201267429329822570934
   PubMed Web of Science ®Google Scholar
• WeiZHaoJYuanSPaclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterizationInt J Pharm20093761–217618519409463
   PubMed Web of Science ®Google Scholar
• ZhaoLShiYZouSSunMLilLZhailGFormulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and D-a-tocopheryl polyethylene glycol succinateJ Biomed Nanotechnol20117335836521830476
   PubMed Web of Science ®Google Scholar
• KabanovAVBatrakovaEVAlakhovVYPluronic (R) block copolymers as novel polymer therapeutics for drug and gene deliveryJ Control Release2002822–318921212175737
   PubMed Web of Science ®Google Scholar
• RisovicVBoydMChooEWasanKMEffects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male ratsAntimicrob Agents Chemother200347103339334214506053
   PubMed Web of Science ®Google Scholar
• DangiJSVyasSPDixitVKEffect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in ratDrug Dev Ind Pharm19982476316359876507
   PubMed Web of Science ®Google Scholar
• LanceMRWashingtonCDavisSSStructure and toxicity of amphotericin B/triglyceride emulsion formulationsJ Antimicrob Chemother19953611191288537259
   PubMedGoogle Scholar
• SouzaLCSaldivaPHNCampaALipid emulsion reduces subacute toxicity of amphotericin B: a histopathological studyExp Toxicol Pathol200052216917510965993
   PubMedGoogle Scholar
• VakilRKwonGSPEG-phospholipid micelles for the delivery of amphotericin BJ Control Release20051011–338638915822230
   PubMed Web of Science ®Google Scholar
• TanQLiuWGuoCZhaiGPreparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical deliveryInt J Nanomedicine201161621163021904452
   PubMed Web of Science ®Google Scholar
• LiHZhaoXMaYZhaiGLiLLouHEnhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticlesJ Control Release2009133323824418951932
   PubMed Web of Science ®Google Scholar
• YanyuXYunmeiSZhipengCQinengPThe preparation of silybin-phospholipid complex and the study on its pharmacokinetics in ratsInt J Pharm20063071778216300915
   PubMed Web of Science ®Google Scholar
• ZhangXCJacksonJKBurtHMDevelopment of amphiphilic diblock copolymers as micellar carriers of taxolInt J Pharmaceutics19961321–2195206
   Web of Science ®Google Scholar
• ItaliaJLSinghDKumarMNRHigh-performance liquid chromatographic analysis of amphotericin B in rat plasma using alpha-naphthol as an internal standardAnal Chim Acta2009634111011419154818
   PubMed Web of Science ®Google Scholar
• LavasanifarASamuelJKwonGSMicelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin BJ Control Release2001771–215516011689268
   PubMed Web of Science ®Google Scholar
• AllemannEGurnyRDoelkerEDrug-loaded nanoparticles – Preparation methods and drug targeting issuesEur J Pharm Biopharm1993395173191
   Web of Science ®Google Scholar
• ZhangZPTanSWFengSSVitamin E TPGS as a molecular biomate-rial for drug deliveryBiomaterials201233194889490622498300
   PubMed Web of Science ®Google Scholar
• DeepaGAshwanikumarNPillaiJJKumarGSVPolymer nanoparticles – a novel strategy for administration of Paclitaxel in cancer chemotherapyCurr Med Chem201219366207621322834822
   PubMed Web of Science ®Google Scholar
• WangRXiaoRZengZXuLWangJApplication of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copo-lymers and their derivatives as nanomaterials in drug deliveryIntl J Nanomedicine2012741854198
   PubMed Web of Science ®Google Scholar
• RemsbergCMZhaoYTakemotoJKBertramRMDaviesNMForrestMLPharmacokinetic evaluation of a DSPE-PEG2000 micellar formulation of ridaforolimus in ratPharmaceutics201251819324300398
   PubMedGoogle Scholar
• LiSDHuangLStealth nanoparticles: high density but sheddable PEG is a key for tumor targetingJ Control Release2010145317818120338200
   PubMed Web of Science ®Google Scholar
• AllenTMHansenCMartinFRedemannCYau-YoungALiposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochim Biophys Acta19911066129362065067
   PubMed Web of Science ®Google Scholar
• AshokBArlethLHjelmRPRubinsteinIÖnyükselHIn vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporationJ Pharm Sci200493102476248715349957
   PubMed Web of Science ®Google Scholar
• GabizonAABarenholzYBialerMProlongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogsPharm Res19931057037088321835
   PubMed Web of Science ®Google Scholar
• LukyanovANTorchilinVPMicelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugsAdv Drug Deliv Rev20045691273128915109769
   PubMed Web of Science ®Google Scholar
• ImhofAWalterRBSchaffnerAContinuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational studyClin Infect Dis200336894395112684904
   PubMedGoogle Scholar
• ErikssonUSeifertBSchaffnerAComparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trialBMJ2001322728657958211238151
   PubMed Web of Science ®Google Scholar
• PelegAYWoodsMLContinuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patientsJ Antimicrob Chemother200454480380815308606
   PubMed Web of Science ®Google Scholar
• HiemenzJWAmphotericin B deoxycholate administered by continuous infusion: dose the dosage make a difference?Clin Infect Dis200336895295312684905
   PubMedGoogle Scholar